Stock listing
Hanover:BM8 BioMarin Pharmaceutical Inc. Aktie
German listing (Hanover) of BioMarin Pharmaceutical Inc. · home listing NASDAQ:BMRN
Follow BioMarin Pharmaceutical Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BMRN
$58.51 USD +1.02 (+1.8%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BMRN
- Day range
- $57.86 – $59.37 USDOct 30, 2026
- Volume
- 2.27M sharesOct 30, 2026
- Market cap
- $11.33B USDAt the close on Oct 30, 2026 · price × 193.6M shares outstanding
- 52-week range
- $49.26 – $70.98 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $137.7M USDMedian day 2.13M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BMRN · Home | $58.51 USD | +1.02 (+1.8%) | 2,273,535 | $58.39 | $59.37 | $57.86 | $57.49 | Close on Oct 30, 2026 |
| Frankfurt:BM8 | €52.02 EUR | +2.04 (+4.1%) | — | €51.30 | €52.02 | €51.30 | €49.98 | Close on Oct 30, 2026 |
| B3:B1MR34 | 144.05 BRL | 0.00 (0.0%) | — | 144.05 | 144.05 | 144.05 | 144.05 | Close on Oct 21, 2026 |
| LSE:0HNC | $55.46 USD | -0.18 (-0.3%) | 4,452 | $56.00 | $56.04 | $55.46 | $55.64 | Close on Oct 27, 2026 |
| Munich:BM8 | €50.35 EUR | -0.02 (0.0%) | — | €50.35 | €50.35 | €50.35 | €50.37 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:BMRN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $58.51 | +1.02 | +1.8% | $58.39 | $59.37 | $57.86 | 2,273,535 | |
| $57.49 | +1.49 | +2.7% | $56.58 | $57.51 | $56.29 | 2,616,555 | |
| $56.00 | +0.65 | +1.2% | $55.00 | $56.17 | $54.89 | 2,001,455 | |
| $55.35 | -0.40 | -0.7% | $55.56 | $56.09 | $55.05 | 2,452,323 | |
| $55.75 | -0.20 | -0.4% | $56.60 | $56.89 | $55.34 | 2,359,989 | |
| $55.95 | -0.68 | -1.2% | $56.68 | $56.81 | $55.24 | 1,682,818 | |
| $56.63 | +1.42 | +2.6% | $55.40 | $56.91 | $55.02 | 2,396,857 | |
| $55.21 | -1.23 | -2.2% | $56.40 | $57.00 | $54.91 | 2,506,314 | |
| $56.44 | +1.77 | +3.2% | $55.08 | $56.48 | $54.95 | 3,474,620 | |
| $54.67 | -0.01 | 0.0% | $54.78 | $55.12 | $54.08 | 2,995,697 | |
| $54.68 | -1.37 | -2.4% | $56.32 | $56.53 | $54.44 | 2,627,800 | |
| $56.05 | +0.91 | +1.7% | $56.45 | $57.59 | $55.96 | 2,922,500 | |
| $55.14 | +0.76 | +1.4% | $54.75 | $55.56 | $54.46 | 1,845,600 | |
| $54.38 | -1.01 | -1.8% | $55.30 | $55.66 | $53.93 | 2,661,700 | |
| $55.39 | +0.59 | +1.1% | $55.56 | $55.96 | $54.90 | 2,363,200 | |
| $54.80 | -0.09 | -0.2% | $54.80 | $55.98 | $54.48 | 2,146,400 | |
| $54.89 | -0.31 | -0.6% | $54.95 | $54.97 | $53.90 | 3,098,900 | |
| $55.20 | -1.02 | -1.8% | $56.05 | $56.60 | $54.76 | 2,078,900 | |
| $56.22 | -1.32 | -2.3% | $57.54 | $57.88 | $55.76 | 3,719,000 | |
| $57.54 | +0.36 | +0.6% | $57.11 | $58.11 | $56.82 | 2,407,500 | |
| $57.18 | -1.26 | -2.2% | $58.52 | $58.73 | $57.15 | 2,192,300 | |
| $58.44 | -1.56 | -2.6% | $59.81 | $60.16 | $58.39 | 2,082,400 | |
| $60.00 | +0.13 | +0.2% | $59.90 | $60.71 | $59.37 | 1,797,900 | |
| $59.87 | +0.41 | +0.7% | $59.24 | $60.09 | $58.96 | 1,807,500 | |
| $59.46 | -0.80 | -1.3% | $59.87 | $60.07 | $58.74 | 2,358,000 | |
| $60.26 | -1.09 | -1.8% | $61.50 | $61.50 | $60.17 | 1,791,300 | |
| $61.35 | -0.86 | -1.4% | $62.21 | $62.33 | $61.13 | 1,659,400 | |
| $62.21 | -1.16 | -1.8% | $63.68 | $64.00 | $61.58 | 2,105,200 | |
| $63.37 | -0.69 | -1.1% | $64.34 | $64.79 | $63.35 | 1,962,600 | |
| $64.06 | +0.12 | +0.2% | $64.35 | $64.96 | $63.58 | 1,876,900 | |
| $63.94 | -1.14 | -1.8% | $65.25 | $65.29 | $63.84 | 4,455,900 | |
| $65.08 | +0.35 | +0.5% | $65.34 | $66.21 | $64.97 | 1,380,500 | |
| $64.73 | +0.28 | +0.4% | $64.48 | $65.67 | $64.34 | 2,252,500 | |
| $64.45 | -1.96 | -3.0% | $65.78 | $65.78 | $63.85 | 1,853,800 | |
| $66.41 | +0.73 | +1.1% | $66.27 | $66.88 | $65.72 | 1,336,300 | |
| $65.68 | +0.17 | +0.3% | $65.96 | $66.05 | $65.29 | 1,604,800 | |
| $65.51 | +1.10 | +1.7% | $64.41 | $65.59 | $63.57 | 2,202,700 | |
| $64.41 | -0.22 | -0.3% | $63.83 | $65.33 | $63.64 | 1,949,600 | |
| $64.63 | -1.90 | -2.9% | $65.24 | $66.26 | $64.01 | 1,457,600 | |
| $66.53 | +0.10 | +0.2% | $65.79 | $66.64 | $65.52 | 2,299,200 | |
| $66.43 | -0.54 | -0.8% | $67.30 | $67.70 | $66.32 | 1,477,700 | |
| $66.97 | +2.13 | +3.3% | $65.00 | $67.20 | $64.99 | 2,520,800 | |
| $64.84 | -0.39 | -0.6% | $65.54 | $66.02 | $64.49 | 1,782,400 | |
| $65.23 | +0.56 | +0.9% | $65.95 | $66.30 | $64.33 | 2,299,100 | |
| $64.67 | -0.62 | -0.9% | $64.99 | $65.08 | $64.07 | 1,098,400 | |
| $65.29 | -0.32 | -0.5% | $65.28 | $65.92 | $64.83 | 1,246,000 | |
| $65.61 | -0.51 | -0.8% | $65.62 | $66.53 | $65.33 | 1,884,300 | |
| $66.12 | +1.05 | +1.6% | $65.03 | $66.36 | $65.02 | 1,358,400 | |
| $65.07 | -1.63 | -2.4% | $66.57 | $67.18 | $64.71 | 2,264,400 | |
| $66.70 | -0.98 | -1.4% | $67.55 | $68.34 | $66.52 | 1,593,500 | |
| $67.68 | -1.65 | -2.4% | $68.11 | $68.75 | $67.57 | 1,275,600 | |
| $69.33 | +2.34 | +3.5% | $68.17 | $69.62 | $67.75 | 1,977,500 | |
| $66.99 | +0.35 | +0.5% | $67.21 | $68.27 | $66.84 | 1,942,300 | |
| $66.64 | -0.72 | -1.1% | $67.00 | $67.63 | $66.21 | 2,237,800 | |
| $67.36 | -1.17 | -1.7% | $68.53 | $68.53 | $67.12 | 1,413,500 | |
| $68.53 | -1.71 | -2.4% | $70.35 | $70.35 | $68.36 | 2,317,000 | |
| $70.24 | +0.69 | +1.0% | $68.71 | $70.98 | $68.29 | 2,840,900 | |
| $69.55 | +0.67 | +1.0% | $69.50 | $70.62 | $68.71 | 3,966,000 | |
| $68.88 | +5.07 | +7.9% | $64.23 | $69.27 | $63.37 | 5,036,600 | |
| $63.81 | +2.35 | +3.8% | $64.83 | $64.92 | $62.20 | 4,365,200 | |
| $61.46 | +1.55 | +2.6% | $60.46 | $61.67 | $58.89 | 3,452,600 | |
| $59.91 | -0.81 | -1.3% | $61.46 | $61.48 | $59.78 | 1,685,600 | |
| $60.72 | +0.72 | +1.2% | $59.89 | $60.83 | $59.33 | 1,239,100 | |
| $60.00 | -0.02 | 0.0% | $60.43 | $60.69 | $59.75 | 1,847,000 | |
| $60.02 | -0.56 | -0.9% | $60.38 | $60.80 | $58.92 | 2,377,100 | |
| $60.58 | -0.79 | -1.3% | $60.60 | $60.84 | $59.72 | 1,224,100 |
- Ticker
- Hanover:BM8
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Hanover
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
BioMarin Enters Into Exclusive Worldwide License Agreement With GC Biopharma and Hanmi Pharm for Investigational Next-Generation Enzyme Replacement Therapy, Adding a Second Potential Treatment for Fabry Disease
Latest earnings call · Aug 6, 2026
BioMarin Pharmaceutical (NASDAQ:BMRN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 6, 2026
Q2 2026 Earnings Presentation
Earnings · 28 slides
Calls
Upcoming
BioMarin Pharmaceutical (NASDAQ:BMRN) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Register
Replays
BioMarin Pharmaceutical (NASDAQ:BMRN) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptBioMarin Pharmaceutical (NASDAQ:BMRN) Q1 2026 Earnings Call
Mon, May 04, 2026 · 4:30 PM ET
Watch TranscriptBioMarin Pharmaceutical (NASDAQ:BMRN) Q4 2025 Earnings Call
Mon, Feb 23, 2026 · 4:30 PM ET
Watch Transcript
Latest news
BioMarin Enters Into Exclusive Worldwide License Agreement With GC Biopharma and Hanmi Pharm for Investigational Next-Generation Enzyme Replacement Therapy, Adding a Second Potential Treatment for Fabry Disease
Oct 29, 2026
Closed $57.49 (+2.7%) on Oct 29, 2026
BioMarin to Host Third Quarter 2026 Financial Results Conference Call and Webcast on Monday, November 2, 2026, at 4: 30pm ET
Oct 26, 2026
Closed $55.75 (-0.4%) on Oct 26, 2026
BioMarin Presents New Data Advancing Understanding of Achondroplasia and Hypochondroplasia Treatment at the American Society for Bone and Mineral Research Annual Meeting
Oct 9, 2026
Closed $54.80 (-0.2%) on Oct 9, 2026
BioMarin Appoints Cara Bauer as Chief People Officer
Oct 5, 2026
Closed $56.22 (-2.3%) on Oct 6, 2026
BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress
Oct 2, 2026
Closed $57.18 (-2.2%) on Oct 2, 2026
BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors
Sep 14, 2026
Closed $66.41 (+1.1%) on Sep 14, 2026
BioMarin Announces Positive Results of Phase 3 VOXZOGO® (vosoritide) Study in Hypochondroplasia Published in NEJM Evidence
Sep 9, 2026
Closed $64.41 (-0.3%) on Sep 9, 2026
BioMarin Announces Close of the Alesta Therapeutics Acquisition
Sep 1, 2026
Closed $64.84 (-0.6%) on Sep 1, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 28 slides · Aug 6, 2026
Q1 2026 Earnings Presentation
Earnings · 21 slides · May 4, 2026
Q4 2025 Earnings Presentation
Earnings · 22 slides · Feb 23, 2026
44th Annual J.P. Morgan Healthcare Conference (January 2026)
Conference · 26 slides · Jan 12, 2026
BioMarin Pharmaceutical Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 38 in the last 12 months · 239 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 6, 2026
- Decks
- 53 decks · latest Aug 6, 2026
Where BioMarin Pharmaceutical Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BMRN · Home listing | NASDAQ | United States | USD |
| gettex:BM8 | gettex | Germany | EUR |
| Tradegate:BM8 | Tradegate | Germany | EUR |
| LS Exchange:924801 | LS Exchange | Germany | EUR |
| Frankfurt:BM8 | Frankfurt | Germany | EUR |
| BMV:BMRN | BMV | Mexico | MXN |
| Lang & Schwarz:924801 | Lang & Schwarz | Germany | EUR |
| B3:B1MR34 | B3 | Brazil | BRL |
| LSE:0HNC | LSE | United Kingdom | USD |
| Milan:1BMRN | Milan | Italy | EUR |
| BX Swiss:BM8 | BX Swiss | Switzerland | CHF |
| EUROTLX:4BMRN | EUROTLX | Italy | EUR |
| Munich:BM8 | Munich | Germany | EUR |
| VIE:BMRN | Vienna | Austria | EUR |
| BOATS:BMRN | BOATS | United States | USD |
| Dusseldorf:BM8 | Dusseldorf | Germany | EUR |
| Hamburg:BM8 | Hamburg | Germany | EUR |
| Hanover:BM8 · This page | Hanover | Germany | EUR |
| Stuttgart:BM8 | Stuttgart | Germany | EUR |
| BIVA:BMRN | BIVA | Mexico | MXN |
Log in to ask 6ix AI your own questions about BioMarin Pharmaceutical Inc.